Measuring Surgical Recovery After Radical Cystectomy
2 other identifiers
observational
2,000
1 country
11
Brief Summary
The intent of this study is to establish a registry of post-surgical outcomes in patients undergoing radical cystectomy at MD Anderson Cancer Center and the collaborating institutions. The goals of this initiative are to obtain a detailed baseline of multiple patient-reported outcomes (PRO) and clinician-reported outcomes (CRO) as well as various presenting conditions associated with them, so that future quality improvement interventions can be evaluated accurately as to their relative contribution to improved outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2015
Longer than P75 for all trials
11 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 30, 2015
CompletedFirst Submitted
Initial submission to the registry
June 16, 2017
CompletedFirst Posted
Study publicly available on registry
June 21, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2034
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2034
April 15, 2026
April 1, 2026
19.7 years
June 16, 2017
April 10, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Post-Surgical Outcomes in Patients Undergoing Radical Cystectomy
Post-surgical outcomes determined from patient-reported assessment of symptom burden using the MD Anderson Symptom Inventory (MDASI-BLC form).
3 months
Study Arms (1)
Bladder Cancer Patients Undergoing Radical Cystectomy
Prospective registry of bladder cancer patients undergoing radical cystectomy at MD Anderson Cancer Center and the collaborating centers.
Interventions
Multi-institutional prospective database of patients with bladder cancer undergoing radical cystectomy.
Eligibility Criteria
Bladder cancer patients undergoing radical cystectomy at the MD Anderson Cancer Center and the collaborating centers.
You may qualify if:
- \. Bladder cancer patients undergoing radical cystectomy at the MD Anderson Cancer Center and the collaborating centers.
You may not qualify if:
- N/A
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (11)
University of California - San Francisco
San Francisco, California, 94143, United States
Stanford University
Stanford, California, 94305, United States
Emory University
Atlanta, Georgia, 30322, United States
University of Chicago
Chicago, Illinois, 60637, United States
University of Kansas Medical Center
Lawrence, Kansas, 66045, United States
John Hopkins Medical Institutions
Baltimore, Maryland, 21205, United States
Spectrum Health Medical Group
Grand Rapids, Michigan, 49503, United States
Winthrop University Hospital
Mineola, New York, 11501, United States
University of Rochester
Rochester, New York, 14611, United States
University of Texas - Southwestern
Dallas, Texas, 75390, United States
University of Texas MD Anderson Cancer Center
Houston, Texas, 77339, United States
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Neema Navai, MD
M.D. Anderson Cancer Center
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 3 Months
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 16, 2017
First Posted
June 21, 2017
Study Start
April 30, 2015
Primary Completion (Estimated)
December 31, 2034
Study Completion (Estimated)
December 31, 2034
Last Updated
April 15, 2026
Record last verified: 2026-04